BDX Q3 2020 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$59B

Q3 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3.9B-11.4% YoY

Gross Profit

$1.7B43.1% margin

Operating Income

$358M9.3% margin

Net Income

$286M7.4% margin

EPS (Diluted)

$0.97

QoQ Revenue Growth

-9.4%

Cash Flow

Operating Cash Flow

$862M

Free Cash Flow

$660M

Stock-Based Comp.

$52M

Balance Sheet

Total Assets

$54.0B

Total Liabilities

$29.9B

Stockholders' Equity

$24.0B

Cash & Equivalents

$2.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.9B	$4.3B	-11.4%
Gross Profit	$1.7B	$2.1B	-20.0%
Operating Income	$358M	$626M	-42.8%
Net Income	$286M	$451M	-36.6%

Revenue Segments

Medical

$2.1B55%

Life Sciences

$951M25%

Interventional

$782M20%

Geographic Segments

UNITED STATES

$2.1B55%

Non-US

$1.7B45%